MedPath

Bilva taila karnapoorana with Brahmi ghrita orally in the management of tinnitus

Phase 2
Conditions
Health Condition 1: H931- Tinnitus
Registration Number
CTRI/2023/01/049235
Lead Sponsor
Dr Mohammed Irfan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects within the age of 21 to 60 years irrespective of gender, occupation, religion, socio- economic status and duration of illness. 1. Subjects having mild to moderate hearing loss. 2. Subjects who fulfill the diagnostic Criteria. 3. Subjects willing to participate in the study with written informed consent, which is conveyed in the language which the subject can understand. 4. Subjects with tinnitus who were not undergoing treatment for tinnitus in the last six months.

Exclusion Criteria

1. Subjects having perforated tympanic membrane.

2. Subjects having any uncontrolled systemic illness which can interfere with the course of disease and treatment.

3. Subjects having congenital deformity of ear.

4. Subjects diagnosed with other diseases like tumors of ear, Aneurysms of carotid artery, Meningitis, Meniereâ??s disease, Acute suppurative otitis media and Chronic suppurative otitis media.

5. Subjects with hearing aids, hearing asymmetry or retro cochlear pathology, metabolic or psychiatric diseases.

6. Subjectsâ?? incapable of filling/answering Tinnitus Handicap Inventory, Clinical Global Impression of Improvement (CGI-I) scale.

7. Pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. karnanada (noise in the ear) <br/ ><br>2. karnapratinaha <br/ ><br>3.Tinnitus handicap inventory,Tinnitus Handicap Inventory SEVERITY SCALE <br/ ><br>4.Clinical Global Impression of Improvement (CGI-I)Timepoint: 1. 0th day â?? Pre- study Assessment <br/ ><br>2. 7th day â?? Assessment during trail period <br/ ><br>3. 30th day - Post study assessment <br/ ><br>4. 45th day â?? Drug free follow-up assessment. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Pure tone audiometryTimepoint: Pure tone audiometry will be done on 0th day and 45th day.
© Copyright 2025. All Rights Reserved by MedPath